AU2009901129A0 - Humanised antibodies with anti-tumour activity - Google Patents

Humanised antibodies with anti-tumour activity

Info

Publication number
AU2009901129A0
AU2009901129A0 AU2009901129A AU2009901129A AU2009901129A0 AU 2009901129 A0 AU2009901129 A0 AU 2009901129A0 AU 2009901129 A AU2009901129 A AU 2009901129A AU 2009901129 A AU2009901129 A AU 2009901129A AU 2009901129 A0 AU2009901129 A0 AU 2009901129A0
Authority
AU
Australia
Prior art keywords
humanised antibodies
tumour activity
tumour
activity
humanised
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2009901129A
Inventor
gvien Not
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teva Pharmaceuticals Australia Pty Ltd
Original Assignee
Arana Therapeutics Ltd
Filing date
Publication date
Application filed by Arana Therapeutics Ltd filed Critical Arana Therapeutics Ltd
Publication of AU2009901129A0 publication Critical patent/AU2009901129A0/en
Priority to MX2011009704A priority Critical patent/MX2011009704A/en
Priority to MA34251A priority patent/MA33194B1/en
Priority to EP10752991A priority patent/EP2408820A4/en
Priority to PCT/AU2010/000298 priority patent/WO2010105290A1/en
Priority to CN201080011960.8A priority patent/CN102395604B/en
Priority to CA2769276A priority patent/CA2769276A1/en
Priority to JP2012500004A priority patent/JP5746134B2/en
Priority to AU2010225448A priority patent/AU2010225448B2/en
Priority to BRPI1009460A priority patent/BRPI1009460A2/en
Priority to UAA201112103A priority patent/UA108349C2/en
Priority to SG2011056751A priority patent/SG173577A1/en
Priority to US12/725,192 priority patent/US8470320B2/en
Priority to NZ594668A priority patent/NZ594668A/en
Priority to KR1020117023016A priority patent/KR20110129935A/en
Priority to EP11183705.0A priority patent/EP2433967A3/en
Priority to EA201171133A priority patent/EA024695B1/en
Priority to NZ600915A priority patent/NZ600915A/en
Priority to ZA2011/05875A priority patent/ZA201105875B/en
Priority to TN2011000417A priority patent/TN2011000417A1/en
Priority to IL214840A priority patent/IL214840A/en
Priority to US13/898,666 priority patent/US8901279B2/en
Priority to CL2013003077A priority patent/CL2013003077A1/en
Abandoned legal-status Critical Current

Links

AU2009901129A 2009-03-16 2009-03-16 Humanised antibodies with anti-tumour activity Abandoned AU2009901129A0 (en)

Priority Applications (22)

Application Number Priority Date Filing Date Title
UAA201112103A UA108349C2 (en) 2009-03-16 2010-03-16 Humanized antibody with antitumor activity
EP10752991A EP2408820A4 (en) 2009-03-16 2010-03-16 Humanised antibodies with anti-tumour activity
NZ600915A NZ600915A (en) 2009-03-16 2010-03-16 Humanised antibodies with anti-tumour activity
SG2011056751A SG173577A1 (en) 2009-03-16 2010-03-16 Humanised antibodies with anti-tumour activity
PCT/AU2010/000298 WO2010105290A1 (en) 2009-03-16 2010-03-16 Humanised antibodies with anti-tumour activity
CN201080011960.8A CN102395604B (en) 2009-03-16 2010-03-16 There is the humanized antibody of anti-tumor activity
CA2769276A CA2769276A1 (en) 2009-03-16 2010-03-16 Humanised antibodies with anti-tumour activity
JP2012500004A JP5746134B2 (en) 2009-03-16 2010-03-16 Humanized antibody with antitumor activity
AU2010225448A AU2010225448B2 (en) 2009-03-16 2010-03-16 Humanised antibodies with anti-tumour activity
BRPI1009460A BRPI1009460A2 (en) 2009-03-16 2010-03-16 antibody binding domain, antibody, use of a binding domain or antibody, method for detecting the presence of cancer cells in a sample.
NZ594668A NZ594668A (en) 2009-03-16 2010-03-16 Humanised antibodies with anti-tumour activity
MX2011009704A MX2011009704A (en) 2009-03-16 2010-03-16 Humanised antibodies with anti-tumour activity.
US12/725,192 US8470320B2 (en) 2009-03-16 2010-03-16 Humanised antibodies with anti-tumour activity
MA34251A MA33194B1 (en) 2009-03-16 2010-03-16 HUMANIZED ANTIBODIES HAVING ANTITUMOR ACTIVITY
KR1020117023016A KR20110129935A (en) 2009-03-16 2010-03-16 Humanised antibodies with anti-tumour activity
EP11183705.0A EP2433967A3 (en) 2009-03-16 2010-03-16 Humanised antibodies with anti-tumour activity
EA201171133A EA024695B1 (en) 2009-03-16 2010-03-16 Humanised antibodies with anti-tumour activity
ZA2011/05875A ZA201105875B (en) 2009-03-16 2011-08-11 Humanised antibodies with anti-tumour activity
TN2011000417A TN2011000417A1 (en) 2009-03-16 2011-08-12 Humanised antibodies with anti-tumour activity
IL214840A IL214840A (en) 2009-03-16 2011-08-25 Humanised antibodies with anti-tumour activity
US13/898,666 US8901279B2 (en) 2009-03-16 2013-05-21 Humanized antibodies with anti-tumor activity
CL2013003077A CL2013003077A1 (en) 2009-03-16 2013-10-24 Humanized antibody with antitumor activity; link domain vh and vl thereof; and in vitro method to detect the presence of cancer cells in a sample (div.sol.no 2290-11).

Publications (1)

Publication Number Publication Date
AU2009901129A0 true AU2009901129A0 (en) 2009-04-02

Family

ID=

Similar Documents

Publication Publication Date Title
AU2013207589A1 (en) Anti-Siglec-15 Antibody
EP2593142B8 (en) Multifunctional antibody conjugates
PL3023438T3 (en) Anti-gitr antibodies
IL220404A (en) Humanized antibodies
ZA201200166B (en) Muc1 antibodies
IL214996A0 (en) Anti-bcma antibodies
IL216147A0 (en) Humanized axl antibodies
ZA201104545B (en) Anti-siglec-15 antibody
GB0909906D0 (en) Antibodies
IL217919A0 (en) Humanized anti-cdcp1 antibodies
EP2565268A4 (en) Novel muc1 antibody
EP2427496A4 (en) Anti-vegf-d antibodies
IL214840A0 (en) Humanised antibodies with anti-tumour activity
GB0920324D0 (en) Antibodies
IL214959A0 (en) Humanized pcrv antibody having anti-pseudomonal activity
GB0905972D0 (en) Antibodies against IL-17BR
GB2473934B (en) Anti-VEEV antibody
EP2499256A4 (en) Anti-c-mpl antibodies
EP2424892A4 (en) Dc-stamp antibodies
WO2012018801A9 (en) Suppressing bone loss with anti-il-19 antibody
AU2009901129A0 (en) Humanised antibodies with anti-tumour activity
GB0908945D0 (en) Antibodies
GB0911712D0 (en) Antibody